Literature DB >> 20199782

Plasma fetuin-A concentrations in young and older high- and low-active men.

Nathan T Jenkins1, Jennifer A McKenzie, James M Hagberg, Sarah Witkowski.   

Abstract

Fetuin-A is a liver-derived factor that may play a role in insulin resistance and age-related chronic diseases (eg, type 2 diabetes mellitus and cardiovascular [CV] disease). Regular exercise improves CV risk and insulin sensitivity; however, it is unknown whether chronic exercise training is related to circulating levels of fetuin-A. Therefore, this study examined whether plasma fetuin-A levels were related to age and chronic physical activity in men. We hypothesized that chronic physical activity would be related to lower plasma fetuin-A levels in younger and older men. In healthy high-active (HI) and low-active (LO) young (HI, n = 7; LO, n = 8) and older (HI, n = 12, LO, n = 11) men, we determined cardiorespiratory fitness (maximal oxygen uptake), plasma fetuin-A levels, plasma insulin, insulin resistance (homeostasis model assessment of insulin resistance), and the standard risk factors for CV disease. Groups were matched for body mass index. Fetuin-A was significantly higher (~20%) in both young and older LO men compared with their HI counterparts, and fetuin-A was inversely related to maximal oxygen uptake (r = -0.40, P = .014). Plasma fetuin-A levels showed trends to be significantly correlated with insulin (r = -0.34, P = .052) and homeostasis model assessment of insulin resistance (r = 0.33, P = .058) in the older individuals. In younger participants, fetuin-A was related to blood pressure and cholesterol measures. These results indicate that low levels of fetuin-A are related to cardiorespiratory fitness and a number of conventional CV and metabolic disease risk factors independent of age and body mass index. Therefore, the maintenance of low levels of circulating fetuin-A may be a novel mechanism contributing to enhanced insulin sensitivity with regular physical activity.
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199782      PMCID: PMC2900414          DOI: 10.1016/j.metabol.2010.01.026

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  28 in total

1.  The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor.

Authors:  G Rauth; O Pöschke; E Fink; M Eulitz; S Tippmer; M Kellerer; H U Häring; P Nawratil; M Haasemann; W Jahnen-Dechent
Journal:  Eur J Biochem       Date:  1992-03-01

2.  Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects.

Authors:  Katsuhito Mori; Masanori Emoto; Hisayo Yokoyama; Takahiro Araki; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

3.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

Review 4.  The anti-inflammatory effect of exercise.

Authors:  Anne Marie W Petersen; Bente Klarlund Pedersen
Journal:  J Appl Physiol (1985)       Date:  2005-04

5.  Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

Authors:  Norbert Stefan; Anita M Hennige; Harald Staiger; Jürgen Machann; Fritz Schick; Stefan M Kröber; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Diabetes Care       Date:  2006-04       Impact factor: 19.112

6.  Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.

Authors:  Joachim H Ix; Michael G Shlipak; Vincent M Brandenburg; Sadia Ali; Markus Ketteler; Mary A Whooley
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 8.  Prevention of non-insulin-dependent diabetes mellitus with physical activity.

Authors:  S P Helmrich; D R Ragland; R S Paffenbarger
Journal:  Med Sci Sports Exerc       Date:  1994-07       Impact factor: 5.411

9.  Relationship between circulating progenitor cells, vascular function and oxidative stress with long-term training and short-term detraining in older men.

Authors:  Sarah Witkowski; Michael M Lockard; Nathan T Jenkins; Thomas O Obisesan; Espen E Spangenburg; James M Hagberg
Journal:  Clin Sci (Lond)       Date:  2010-02       Impact factor: 6.124

10.  Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study.

Authors:  Eva Fisher; Norbert Stefan; Kathrin Saar; Dagmar Drogan; Matthias B Schulze; Andreas Fritsche; Hans-Georg Joost; Hans-Ulrich Häring; Norbert Hubner; Heiner Boeing; Cornelia Weikert
Journal:  Circ Cardiovasc Genet       Date:  2009-09-05
View more
  11 in total

1.  Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity.

Authors:  Steven K Malin; Juan Pablo del Rincon; Hazel Huang; John P Kirwan
Journal:  Med Sci Sports Exerc       Date:  2014-11       Impact factor: 5.411

Review 2.  Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus.

Authors:  Sazan Rasul; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Endocrine       Date:  2012-07-21       Impact factor: 3.633

Review 3.  The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies.

Authors:  F Roshanzamir; M Miraghajani; M H Rouhani; M Mansourian; R Ghiasvand; S M Safavi
Journal:  J Endocrinol Invest       Date:  2017-06-22       Impact factor: 4.256

4.  Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients.

Authors:  Céline Maréchal; Georg Schlieper; Pauline Nguyen; Thilo Krüger; Emmanuel Coche; Annie Robert; Jorgen Floege; Eric Goffin; Michel Jadoul; Olivier Devuyst
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-28       Impact factor: 8.237

5.  Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.

Authors:  Xiaowen Liu; Ole-Petter R Hamnvik; John P Chamberland; Michael Petrou; Huizhi Gong; Costas A Christophi; David C Christiani; Stefanos N Kales; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-03-15       Impact factor: 8.694

6.  AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?

Authors:  X Julia Xu; Rudy J Valentine; Neil B Ruderman
Journal:  Curr Obes Rep       Date:  2014-06-01

7.  Fetuin A concentration in the second trimester amniotic fluid of fetuses with trisomy 21 appears to be lower: phenotypic considerations.

Authors:  S Iliodromiti; N Vrachnis; Evangelia Samoli; Z Iliodromiti; C Pangalos; N Drakoulis; G Creatsas; D Botsis
Journal:  Mediators Inflamm       Date:  2012-02-06       Impact factor: 4.711

Review 8.  Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

Authors:  Paulo Linhares; Bruno Carvalho; Rui Vaz; Bruno M Costa
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

9.  Serum fetuin-A and Ser312 phosphorylated fetuin-A responses and markers of insulin sensitivity after a single bout of moderate intensity exercise.

Authors:  Guang Ren; Robert L Bowers; Teayoun Kim; Alonzo J Mahurin; Peter W Grandjean; Suresh T Mathews
Journal:  Physiol Rep       Date:  2021-03

10.  Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease.

Authors:  Steven K Malin; Anny Mulya; Ciaran E Fealy; Jacob M Haus; Mangesh R Pagadala; Amanda R Scelsi; Hazel Huang; Chris A Flask; Arthur J McCullough; John P Kirwan
Journal:  J Appl Physiol (1985)       Date:  2013-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.